[Esketamine alleviates depression-like behaviors in mice with chronic restraint stress by activating glutamatergic neurons in the medial prefrontal cortex].

Read full text Summarise with VIRAT
Authors: Zhuoning Zhang, Xinyu Hao, Fuyang Cao, Yongxin Guo, Shuting Guo, Chen Cai, Weidong Mi, Li Tong
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVES: To investigate the regulatory role of glutamatergic neurons in the medial prefrontal cortex (mPFC) in the antidepressant effects of esketamine. METHODS: 10). The mice subjected to the chronic restraint stress (CRS), and those exhibiting depressive-like behaviors following CRS received either esketamine or saline treatment, and subsequent behavioral changes were evaluated. Depressive-like behaviors were assessed using tail suspension test (TST), forced swim test (FST), and sucrose preference test (SPT). The changes in neuronal activity within the mPFC were examined using c-Fos immunofluorescence staining. To explore the underlying mechanism, chemogenetic approaches were employed to specifically modulate the activity of mPFC glutamatergic neurons and examine how these manipulations influenced the effect of esketamine on behaviors of the mice. RESULTS:

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Tryptophan and brain disorders

Publication details

Journal / source
PubMed Central
Volume
46
Issue
3
Pages
489–496
Publication date
20 March 2026
Language
ZH